GlassScriptPhysician profile
William T Cullen
NPI 1518916535
$3,336.28
in general payments reported to CMS, 2019-2025
10 companies · $1,659 in 2025
The $1,659 reported for 2025 was more than what 80% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $59.99 · 2021: $277 · 2022: $425 · 2023: $378 · 2024: $433 · 2025: $1,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,303 · Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,303.20 |
| Food and Beverage | $1,166.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,752.70 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $1,359.91 | 2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Sientra, INC. | $73.40 | 2021 | |
| Organogenesis INC. | $34.57 | 2023 | Puraply |
| W. L. Gore & Associates, INC. | $27.25 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Abbvie INC. | $21.85 | 2024 | |
| Stryker Corporation | $21.33 | 2024 | Dart-Fire, Conextions Tr Tendon Repair System-Implant Mechanism |
| Allergan, INC. | $17.15 | 2022 | |
| Davol INC. | $16.38 | 2022 | |
| Endo Pharmaceuticals INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.